nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Hypertensive crisis—Sorafenib—liver cancer	0.0579	0.0579	CcSEcCtD
Esmolol—Electrocardiogram ST segment depression—Epirubicin—liver cancer	0.0261	0.0262	CcSEcCtD
Esmolol—Electrocardiogram ST segment depression—Doxorubicin—liver cancer	0.0242	0.0242	CcSEcCtD
Esmolol—Pleural effusion—Sorafenib—liver cancer	0.021	0.021	CcSEcCtD
Esmolol—Myocardial ischaemia—Sorafenib—liver cancer	0.02	0.02	CcSEcCtD
Esmolol—Skin necrosis—Epirubicin—liver cancer	0.017	0.017	CcSEcCtD
Esmolol—Supraventricular extrasystoles—Epirubicin—liver cancer	0.0159	0.0159	CcSEcCtD
Esmolol—Skin necrosis—Doxorubicin—liver cancer	0.0157	0.0157	CcSEcCtD
Esmolol—Skin exfoliation—Sorafenib—liver cancer	0.0153	0.0153	CcSEcCtD
Esmolol—Neuropathy—Sorafenib—liver cancer	0.0151	0.0151	CcSEcCtD
Esmolol—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.0147	0.0147	CcSEcCtD
Esmolol—Cardiac failure congestive—Sorafenib—liver cancer	0.0129	0.0129	CcSEcCtD
Esmolol—Cardiac failure—Sorafenib—liver cancer	0.0119	0.012	CcSEcCtD
Esmolol—Pneumothorax—Epirubicin—liver cancer	0.0119	0.0119	CcSEcCtD
Esmolol—Pneumothorax—Doxorubicin—liver cancer	0.011	0.011	CcSEcCtD
Esmolol—Nasopharyngitis—Sorafenib—liver cancer	0.0104	0.0104	CcSEcCtD
Esmolol—Abdominal discomfort—Sorafenib—liver cancer	0.00966	0.00966	CcSEcCtD
Esmolol—Psoriasis—Epirubicin—liver cancer	0.00944	0.00945	CcSEcCtD
Esmolol—Acute coronary syndrome—Sorafenib—liver cancer	0.00886	0.00886	CcSEcCtD
Esmolol—Neuropathy peripheral—Sorafenib—liver cancer	0.00881	0.00881	CcSEcCtD
Esmolol—Myocardial infarction—Sorafenib—liver cancer	0.00881	0.00881	CcSEcCtD
Esmolol—Psoriasis—Doxorubicin—liver cancer	0.00874	0.00874	CcSEcCtD
Esmolol—Blister—Epirubicin—liver cancer	0.00824	0.00824	CcSEcCtD
Esmolol—Urinary tract disorder—Sorafenib—liver cancer	0.00797	0.00797	CcSEcCtD
Esmolol—Urethral disorder—Sorafenib—liver cancer	0.00791	0.00791	CcSEcCtD
Esmolol—Pleural effusion—Epirubicin—liver cancer	0.00775	0.00775	CcSEcCtD
Esmolol—Blister—Doxorubicin—liver cancer	0.00762	0.00762	CcSEcCtD
Esmolol—Flushing—Sorafenib—liver cancer	0.00749	0.00749	CcSEcCtD
Esmolol—Cardiac disorder—Sorafenib—liver cancer	0.00749	0.00749	CcSEcCtD
Esmolol—Angiopathy—Sorafenib—liver cancer	0.00732	0.00732	CcSEcCtD
Esmolol—Rigors—Epirubicin—liver cancer	0.00727	0.00727	CcSEcCtD
Esmolol—Pleural effusion—Doxorubicin—liver cancer	0.00717	0.00717	CcSEcCtD
Esmolol—Mental disorder—Sorafenib—liver cancer	0.00707	0.00707	CcSEcCtD
Esmolol—Erythema—Sorafenib—liver cancer	0.00702	0.00702	CcSEcCtD
Esmolol—Dysgeusia—Sorafenib—liver cancer	0.00688	0.00688	CcSEcCtD
Esmolol—Extravasation—Epirubicin—liver cancer	0.0068	0.00681	CcSEcCtD
Esmolol—Rigors—Doxorubicin—liver cancer	0.00673	0.00673	CcSEcCtD
Esmolol—Skin discolouration—Epirubicin—liver cancer	0.00657	0.00657	CcSEcCtD
Esmolol—Ventricular extrasystoles—Epirubicin—liver cancer	0.00657	0.00657	CcSEcCtD
Esmolol—Thinking abnormal—Epirubicin—liver cancer	0.00648	0.00649	CcSEcCtD
Esmolol—Oliguria—Epirubicin—liver cancer	0.00644	0.00644	CcSEcCtD
Esmolol—Angioedema—Sorafenib—liver cancer	0.00642	0.00642	CcSEcCtD
Esmolol—Syncope—Sorafenib—liver cancer	0.0063	0.0063	CcSEcCtD
Esmolol—Extravasation—Doxorubicin—liver cancer	0.00629	0.0063	CcSEcCtD
Esmolol—Loss of consciousness—Sorafenib—liver cancer	0.00617	0.00617	CcSEcCtD
Esmolol—Inflammation—Epirubicin—liver cancer	0.00612	0.00612	CcSEcCtD
Esmolol—Atrioventricular block—Epirubicin—liver cancer	0.00612	0.00612	CcSEcCtD
Esmolol—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00608	0.00608	CcSEcCtD
Esmolol—Skin discolouration—Doxorubicin—liver cancer	0.00608	0.00608	CcSEcCtD
Esmolol—Thinking abnormal—Doxorubicin—liver cancer	0.006	0.006	CcSEcCtD
Esmolol—Oliguria—Doxorubicin—liver cancer	0.00596	0.00596	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00594	0.00594	CcSEcCtD
Esmolol—Dry mouth—Sorafenib—liver cancer	0.00585	0.00585	CcSEcCtD
Esmolol—Skin exfoliation—Epirubicin—liver cancer	0.00567	0.00567	CcSEcCtD
Esmolol—Atrioventricular block—Doxorubicin—liver cancer	0.00566	0.00566	CcSEcCtD
Esmolol—Inflammation—Doxorubicin—liver cancer	0.00566	0.00566	CcSEcCtD
Esmolol—Shock—Sorafenib—liver cancer	0.00564	0.00564	CcSEcCtD
Esmolol—Nervous system disorder—Sorafenib—liver cancer	0.00562	0.00562	CcSEcCtD
Esmolol—Neuropathy—Epirubicin—liver cancer	0.00557	0.00557	CcSEcCtD
Esmolol—Skin disorder—Sorafenib—liver cancer	0.00557	0.00557	CcSEcCtD
Esmolol—Anorexia—Sorafenib—liver cancer	0.00546	0.00546	CcSEcCtD
Esmolol—Ecchymosis—Epirubicin—liver cancer	0.00537	0.00537	CcSEcCtD
Esmolol—Pulmonary oedema—Epirubicin—liver cancer	0.00528	0.00529	CcSEcCtD
Esmolol—Skin exfoliation—Doxorubicin—liver cancer	0.00524	0.00525	CcSEcCtD
Esmolol—Abnormal vision—Epirubicin—liver cancer	0.00518	0.00518	CcSEcCtD
Esmolol—Neuropathy—Doxorubicin—liver cancer	0.00516	0.00516	CcSEcCtD
Esmolol—Mental disability—Epirubicin—liver cancer	0.00515	0.00515	CcSEcCtD
Esmolol—Dyspnoea—Sorafenib—liver cancer	0.00511	0.00511	CcSEcCtD
Esmolol—Dyspepsia—Sorafenib—liver cancer	0.00504	0.00505	CcSEcCtD
Esmolol—Decreased appetite—Sorafenib—liver cancer	0.00498	0.00498	CcSEcCtD
Esmolol—Thrombophlebitis—Epirubicin—liver cancer	0.00498	0.00498	CcSEcCtD
Esmolol—Ecchymosis—Doxorubicin—liver cancer	0.00497	0.00497	CcSEcCtD
Esmolol—Gastrointestinal disorder—Sorafenib—liver cancer	0.00495	0.00495	CcSEcCtD
Esmolol—Fatigue—Sorafenib—liver cancer	0.00494	0.00494	CcSEcCtD
Esmolol—Pain—Sorafenib—liver cancer	0.0049	0.0049	CcSEcCtD
Esmolol—Constipation—Sorafenib—liver cancer	0.0049	0.0049	CcSEcCtD
Esmolol—Pulmonary oedema—Doxorubicin—liver cancer	0.00489	0.00489	CcSEcCtD
Esmolol—Abnormal vision—Doxorubicin—liver cancer	0.00479	0.00479	CcSEcCtD
Esmolol—Mental disability—Doxorubicin—liver cancer	0.00477	0.00477	CcSEcCtD
Esmolol—Cardiac failure congestive—Epirubicin—liver cancer	0.00475	0.00475	CcSEcCtD
Esmolol—Thrombophlebitis—Doxorubicin—liver cancer	0.00461	0.00461	CcSEcCtD
Esmolol—Urticaria—Sorafenib—liver cancer	0.00455	0.00455	CcSEcCtD
Esmolol—Body temperature increased—Sorafenib—liver cancer	0.00453	0.00453	CcSEcCtD
Esmolol—Dermatitis bullous—Epirubicin—liver cancer	0.00451	0.00451	CcSEcCtD
Esmolol—Cardiac failure—Epirubicin—liver cancer	0.00442	0.00442	CcSEcCtD
Esmolol—Cardiac failure congestive—Doxorubicin—liver cancer	0.0044	0.0044	CcSEcCtD
Esmolol—Dermatitis bullous—Doxorubicin—liver cancer	0.00417	0.00417	CcSEcCtD
Esmolol—Asthenia—Sorafenib—liver cancer	0.00411	0.00411	CcSEcCtD
Esmolol—Cardiac arrest—Epirubicin—liver cancer	0.0041	0.0041	CcSEcCtD
Esmolol—Cardiac failure—Doxorubicin—liver cancer	0.00409	0.00409	CcSEcCtD
Esmolol—Pruritus—Sorafenib—liver cancer	0.00405	0.00406	CcSEcCtD
Esmolol—Nasopharyngitis—Epirubicin—liver cancer	0.00385	0.00385	CcSEcCtD
Esmolol—Cardiac arrest—Doxorubicin—liver cancer	0.00379	0.00379	CcSEcCtD
Esmolol—Dizziness—Sorafenib—liver cancer	0.00379	0.00379	CcSEcCtD
Esmolol—Vomiting—Sorafenib—liver cancer	0.00364	0.00364	CcSEcCtD
Esmolol—Angina pectoris—Epirubicin—liver cancer	0.00363	0.00363	CcSEcCtD
Esmolol—Headache—Sorafenib—liver cancer	0.00359	0.00359	CcSEcCtD
Esmolol—Nasopharyngitis—Doxorubicin—liver cancer	0.00357	0.00357	CcSEcCtD
Esmolol—Dysuria—Epirubicin—liver cancer	0.00348	0.00348	CcSEcCtD
Esmolol—Nausea—Sorafenib—liver cancer	0.0034	0.0034	CcSEcCtD
Esmolol—Angina pectoris—Doxorubicin—liver cancer	0.00336	0.00336	CcSEcCtD
Esmolol—Drowsiness—Epirubicin—liver cancer	0.00332	0.00332	CcSEcCtD
Esmolol—Neuropathy peripheral—Epirubicin—liver cancer	0.00325	0.00326	CcSEcCtD
Esmolol—Dysuria—Doxorubicin—liver cancer	0.00322	0.00322	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—liver cancer	0.00307	0.00307	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—liver cancer	0.00303	0.00304	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—liver cancer	0.00301	0.00301	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—liver cancer	0.00299	0.00299	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—liver cancer	0.00296	0.00296	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—liver cancer	0.00294	0.00294	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—liver cancer	0.00292	0.00292	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—liver cancer	0.00287	0.00287	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—liver cancer	0.00281	0.00281	CcSEcCtD
Esmolol—Flushing—Epirubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—liver cancer	0.00277	0.00277	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—liver cancer	0.00274	0.00274	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—liver cancer	0.00272	0.00272	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—liver cancer	0.0027	0.00271	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—liver cancer	0.0027	0.0027	CcSEcCtD
Esmolol—Chills—Epirubicin—liver cancer	0.00267	0.00268	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—liver cancer	0.00266	0.00266	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—liver cancer	0.00261	0.00261	CcSEcCtD
Esmolol—Erythema—Epirubicin—liver cancer	0.00259	0.0026	CcSEcCtD
Esmolol—Flushing—Doxorubicin—liver cancer	0.00256	0.00256	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—liver cancer	0.00256	0.00256	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—liver cancer	0.00254	0.00254	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—liver cancer	0.0025	0.0025	CcSEcCtD
Esmolol—Chills—Doxorubicin—liver cancer	0.00247	0.00248	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—liver cancer	0.00242	0.00242	CcSEcCtD
Esmolol—Erythema—Doxorubicin—liver cancer	0.0024	0.0024	CcSEcCtD
Esmolol—Agitation—Epirubicin—liver cancer	0.00238	0.00239	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—liver cancer	0.00235	0.00235	CcSEcCtD
Esmolol—Syncope—Epirubicin—liver cancer	0.00233	0.00233	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—liver cancer	0.00228	0.00228	CcSEcCtD
Esmolol—Convulsion—Epirubicin—liver cancer	0.00225	0.00225	CcSEcCtD
Esmolol—Chest pain—Epirubicin—liver cancer	0.00221	0.00221	CcSEcCtD
Esmolol—Agitation—Doxorubicin—liver cancer	0.00221	0.00221	CcSEcCtD
Esmolol—Anxiety—Epirubicin—liver cancer	0.0022	0.0022	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00219	0.00219	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—liver cancer	0.00216	0.00216	CcSEcCtD
Esmolol—Syncope—Doxorubicin—liver cancer	0.00215	0.00215	CcSEcCtD
Esmolol—Confusional state—Epirubicin—liver cancer	0.00214	0.00214	CcSEcCtD
Esmolol—Oedema—Epirubicin—liver cancer	0.00212	0.00212	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—liver cancer	0.00211	0.00211	CcSEcCtD
Esmolol—Shock—Epirubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—liver cancer	0.00208	0.00208	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—liver cancer	0.00206	0.00206	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—liver cancer	0.00205	0.00205	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—liver cancer	0.00204	0.00204	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00203	0.00203	CcSEcCtD
Esmolol—Anorexia—Epirubicin—liver cancer	0.00202	0.00202	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—liver cancer	0.002	0.002	CcSEcCtD
Esmolol—Hypotension—Epirubicin—liver cancer	0.00198	0.00198	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—liver cancer	0.00198	0.00198	CcSEcCtD
Esmolol—Oedema—Doxorubicin—liver cancer	0.00196	0.00196	CcSEcCtD
Esmolol—Shock—Doxorubicin—liver cancer	0.00193	0.00193	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—liver cancer	0.00192	0.00192	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—liver cancer	0.0019	0.0019	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—liver cancer	0.00189	0.00189	CcSEcCtD
Esmolol—Somnolence—Epirubicin—liver cancer	0.00188	0.00188	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—liver cancer	0.00187	0.00187	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—liver cancer	0.00186	0.00186	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—liver cancer	0.00184	0.00184	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Fatigue—Epirubicin—liver cancer	0.00183	0.00183	CcSEcCtD
Esmolol—Constipation—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Esmolol—Pain—Epirubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—liver cancer	0.00176	0.00176	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—liver cancer	0.00175	0.00175	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—liver cancer	0.00174	0.00174	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—liver cancer	0.00172	0.00173	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—liver cancer	0.0017	0.0017	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—liver cancer	0.00169	0.00169	CcSEcCtD
Esmolol—Urticaria—Epirubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Pain—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Constipation—Doxorubicin—liver cancer	0.00168	0.00168	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—liver cancer	0.00167	0.00167	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—liver cancer	0.00161	0.00162	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—liver cancer	0.00156	0.00156	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—liver cancer	0.00155	0.00155	CcSEcCtD
Esmolol—Asthenia—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Esmolol—Pruritus—Epirubicin—liver cancer	0.0015	0.0015	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Esmolol—Dizziness—Epirubicin—liver cancer	0.0014	0.0014	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Esmolol—Vomiting—Epirubicin—liver cancer	0.00135	0.00135	CcSEcCtD
Esmolol—Headache—Epirubicin—liver cancer	0.00133	0.00133	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—liver cancer	0.0013	0.0013	CcSEcCtD
Esmolol—Nausea—Epirubicin—liver cancer	0.00126	0.00126	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—liver cancer	0.00125	0.00125	CcSEcCtD
Esmolol—Headache—Doxorubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Esmolol—Nausea—Doxorubicin—liver cancer	0.00116	0.00116	CcSEcCtD
Esmolol—Ibuprofen—PPARG—liver cancer	0.000148	0.507	CrCbGaD
Esmolol—Propranolol—CYP1A1—liver cancer	8.79e-05	0.302	CrCbGaD
Esmolol—Ibuprofen—ALB—liver cancer	5.56e-05	0.191	CrCbGaD
